Status:
COMPLETED
Use of Lactic Acid Gel for Intravaginal Use, 7 Applicators x 5ml, Bayer to Reduce Post-episiotomy Discomfort
Lead Sponsor:
Saint Andrew Hospital Constanta
Collaborating Sponsors:
Ovidius University of Constanta
Conditions:
Episiotomy
Wound Healing
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
This prospective controlled study evaluates the efficacy of topical lactic acid gel in enhancing episiotomy wound healing and improving postpartum sexual quality of life.
Detailed Description
This prospective controlled clinical study aims to evaluate the efficacy of topical lactic acid gel in promoting the healing of episiotomy wounds and improving postpartum sexual quality of life. The ...
Eligibility Criteria
Inclusion
- Women aged 18-40 years
- Spontaneous vaginal delivery with mediolateral episiotomy at 38-40 weeks gestation
- No pre-existing wound healing disorders or infections
- Provided informed consent
Exclusion
- Known hypersensitivity to lactic acid products
- Third- or fourth-degree perineal tears
- Gestational diabetes or immunosuppressive conditions
- Use of additional wound care treatments
Key Trial Info
Start Date :
January 31 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06978049
Start Date
January 31 2023
End Date
December 31 2023
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Andrew Hospital
Constanța, Constanța County, Romania, 900184